Twitter summary: Medtronic recalls MiniMed products due to minor design error leading to accidental hypo – new design in the works to fix the issue On August 22, the FDA...

Dexcom Share – Peace of Mind for Loved Ones, Paving the Way for Next-Gen Mobile CGM.

Advances in type 1 diabetes at The American Diabetes Association 74th Scientific Sessions

Twitter Summary: Glucose info right on your wrist? Microsoft/Apple rumored smart watches might make that a reality We first wrote about Google’s venture into the...

The Future of Type 1 Diabetes – what challenges and promises lie ahead? Part two of our interview with David Panzirer and Dana Ball.

Kerri Sparling ( Sixuntilme.com ) discusses CGM in the Cloud, explaining what it is and how it works. Sparling writes about its benefits and drawbacks that are leading...

Twitter summary: Dexcom announces “Software 505” for CGM users – FREE download that improves accuracy to 9% vs. fingersticks, available now! In unexpected news, Dexcom...

On July 15, Novartis announced a partnership with Google[x] to develop smart contact lenses that can non-invasively track blood glucose levels through tears and send the...

Robo-doctors? How new technologies might change the way you meet with your health care provider.

On April 22, the FDA announced an exciting new program to accelerate access to medical devices that address major unmet needs. This should mean earlier and more...

Twitter Summary: Abbott receives EU Approval to launch Freestyle Libre – updates from EASD on payment, device accuracy, design, and user experience On September 3,...

An illuminating FDA workshop on bolus calculators and device interoperability identifies key unmet needs in diabetes technology - Adam Brown makes a patient presentation!

On July 3, Dr. Ed Damiano addressed the Friends for Life Conference in Orlando with the latest update on his team’s bionic pancreas, which involves automated insulin+...

Twitter Summary: Insulet’s next-gen PDM will integrate with Dexcom’s Gen 5 CGM and mobile app – like so many patients had always hoped! On August 5, Insulet announced...

On April 29, the FDA issued a strongly-worded safety communication that advised patients and health care providers to stop using the GenStrip from Shasta Technologies, a...

Twitter Summary: FDA approves Trulicity for #T2D, 1 st ready-to-use once-weekly GLP-1 agonist in the US, with a patient-friendly “auto-injector” – launch for later this...

Twitter summary: @LillyDiabetes launches Trulicity in the US – first ready-to-use once-weekly GLP-1, available w/savings program for commercially insured On November 10...

On July 9, NeuroMetrix announced that the FDA had granted clearance for over-the-counter use of the Sensus pain management system for diabetic peripheral neuropathy (DPN...

Twitter summary: Asante MySnap allows users to customize the design of their pumps, plus a new “upgrade” program and plans for a next-generation pump At AADE in August,...

German pharmaceutical company Merck KGaA has launched a pilot program in Kenya and Uganda to improve the outcomes of diabetes care through a text messaging campaign...